Introduction Market Access is critical to commercial success, so the whole organisation needs to be ...
Read moreIntroduction Market access is a constantly developing field with regular updates across various coun...
Read moreIntroduction Payer negotiations can be the most challenging situations that market access teams enco...
Read moreThe EUNetHTA recently published its draft scoping guidance which outlines how the contrasting decisi...
Read moreEUnetHTA and the EU Joint HTA Process EUnetHTA was established in 2006 to facilitate information sha...
Read moreIntroduction Achieving access to patients for innovative treatments is becoming a significant challe...
Read moreThe Innovative Medicines Fund launched on 7th June 2022 The Innovative Medicines Fund (IMF), which w...
Read moreEUnetHTA and the EU Joint HTA Process Originally set up in 2006, EUnetHTA was established to facilit...
Read moreIntroduction For some manufacturers, launching in the Middle East and North Africa (MENA) is fraught...
Read moreIntroduction As the most populous country in the world with 1.4 billion inhabitants, China has the p...
Read more